Online citations, reference lists, and bibliographies.
← Back to Search

Use Of Computed Tomography And Positron Emission Tomography/Computed Tomography For Staging Of Local Extent In Patients With Malignant Pleural Mesothelioma

T. Frauenfelder, P. Kestenholz, R. Hunziker, T. L. Nguyen, Martina Fries, P. Veit-Haibach, L. Husmann, R. Stahel, W. Weder, I. Opitz
Published 2015 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Purpose The objective of this study was to determine the diagnostic value of computed tomography (CT) and positron emission tomography (PET)/CT for staging of malignant pleural mesothelioma (MPM) in patients undergoing induction chemotherapy. Methods Sixty-two patients (median age, 61 years; female: n = 9) with proven MPM underwent CT after induction chemotherapy. Of these, 28 underwent additional PET/CT. Extrapleural pneumonectomy was performed for pathological TNM staging. Clinical TNM stage was assessed by 3 independent readers. Relative and absolute underestimation and overestimation were compared with pathological tumor stage. Sensitivity, specificity, and accuracy for differentiation between stages T2 and T3 were assessed. Interobserver agreement between the readers was analyzed (&kgr;). Results Positron emission tomography/CT and CT underestimated T stage in up to 30% of the cases. Positron emission tomography/CT had a higher accuracy for tumor extent compared with CT (PET/CT: 0.92; CT: 0.84). The accuracy for nodal staging was higher for CT than for PET/CT (PET/CT: 0.78; CT: 0.87). Concerning International Mesothelioma Interest Group classification, PET/CT improved the accuracy of preoperative staging compared with CT (PET/CT: 0.91; CT: 0.82). Interobserver agreement was moderate for CT (0.48–0.62) and good for PET/CT (0.64–0.83) for T staging. For nodal staging, interobserver agreement was fair to moderate for CT and good for PET/CT (CT: 0.37–0.51; PET/CT: 0.73–0.76). Conclusions Positron emission tomography/CT is more accurate and has a lower interobserver variability for clinical intrathoracic staging of MPM compared with CT. Nevertheless PET/CT underestimated tumor stage in a substantial number of cases, showing the need for a more accurate imaging technology or approach.
This paper references
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients.
E. Butchart (1976)
Staging of malignant pleural mesothelioma: comparison of CT and MR imaging.
R. Heelan (1999)
Integrated positron emission tomography-computed tomography does not accurately stage intrathoracic disease of patients undergoing trimodality therapy for malignant pleural mesothelioma.
J. Pilling (2010)
Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group.
S. Armato (2013)
What is the best way to diagnose and stage malignant pleural mesothelioma?
I. Zahid (2011)
Fast T1- and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma.
M. Both (2005)
Computed Tomography, Positron Emission Tomography, Positron Emission Tomography/Computed Tomography, and Magnetic Resonance Imaging for Staging of Limited Pleural Mesothelioma: Initial Results
C. Plathow (2008)
An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers.
J. Landis (1977)
Thin-section CT of the mediastinum in preoperative N-staging of non-small cell lung cancer: comparison with FDG PET.
A. Nambu (2010)
A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group.
V. Rusch (1995)
Pleurectomy/Decortication is Superior to Extrapleural Pneumonectomy in the Multimodality Management of Patients with Malignant Pleural Mesothelioma
L. Lang-Lazdunski (2012)
Thymidylate Synthase and Excision Repair Cross-Complementing Group-1 as Predictors of Responsiveness in Mesothelioma Patients Treated with Pemetrexed/Carboplatin
P. A. Zucali (2011)
Preoperative staging of mesothelioma by 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography fused imaging and mediastinoscopy compared to pathological findings after extrapleural pneumonectomy.
J. Sørensen (2008)
A Systematic Review of Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma
C. Cao (2010)
Morphologic and functional imaging of malignant pleural mesothelioma.
M. Yamamuro (2007)
American Joint Committee of Cancer. AJCC Cancer Staging Manual
Malignant pleural mesothelioma: staging systems.
P. V. Schil (2005)
Malignant pleural mesothelioma: role of CT, MRI, and PET/CT in staging evaluation and treatment considerations.
M. Truong (2013)
Robust data: the essential foundation of a revised staging system for pleural mesothelioma.
H. Kindler (2012)
Initial Analysis of the International Association For the Study of Lung Cancer Mesothelioma Database
V. Rusch (2012)
TNM Classification of Malignant Tumours
L. Sobin (1987)
Volumetry: an alternative to assess therapy response for malignant pleural mesothelioma?
T. Frauenfelder (2011)
Noninvasive staging of non-small cell lung cancer: a review of the current evidence.
E. Toloza (2003)
Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma.
R. Flores (2003)
Promising Early Local Control of Malignant Pleural Mesothelioma Following Postoperative Intensity Modulated Radiotherapy (IMRT) to the Chest
A. Ahamad (2003)
Integrated computed tomography-positron emission tomography in patients with potentially resectable malignant pleural mesothelioma: Staging implications.
J. Erasmus (2005)
Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma.
D. Sugarbaker (1993)

This paper is referenced by
Malignant Pleural Mesothelioma: Diagnosis, Staging, Pitfalls and Follow-up.
Erika G Odisio (2017)
Risk factors and biomarkers for malignant mesothelioma
Vasiliki Panou (2019)
Delayed-Phase Enhancement for Evaluation of Malignant Pleural Mesothelioma on Computed Tomography: A Prospective Cohort Study.
Akash M Patel (2020)
Pet Applications For Staging And Restaging In Thoracic Malignancies
T. Ones (2015)
Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma.
K. Martini (2016)
Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.
S. Armato (2019)
In Response.
A. Billè (2015)
British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma
I. Woolhouse (2018)
The role of extrapleural pneumonectomy for malignant pleural mesothelioma: reviewing 20-years of experience
Raphael Werner (2020)
Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems.
Susanne R. Youngren-Ortiz (2016)
Impact of tumour thickness on survival after radical radiation and surgery in malignant pleural mesothelioma
M. D. de Perrot (2017)
Pleural mesothelioma: is the surgeon still there?
I. Opitz (2018)
Value of contrast CT in combination with PET/CT in mesothelioma staging: Optimal protocol for initial assessment
M. Houseni (2017)
Diagnostic imaging and workup of malignant pleural mesothelioma
L. Cardinale (2017)
18F-FDG PET/CT in the management of patients with malignant pleural mesothelioma being considered for multimodality therapy: experience of a tertiary referral center.
H. S. Elliott (2018)
Role of Metabolic Imaging in Mesothelioma
Fabrizia Gelardi (2019)
Overview of treatment related complications in malignant pleural mesothelioma.
D. Murphy (2017)
Semantic Scholar Logo Some data provided by SemanticScholar